EU OKs Novartis drug patch for Alzheimer's

09/24/2007 | Forbes

The European Commission has approved Novartis AG's Exelon skin patch for the treatment of Alzheimer's disease, the company said. The patch, which was granted FDA approval last July, administers the drug to treat mild to moderate dementia symptoms.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX